Shuttle Pharmaceuticals Holdings (SHPH) Short term Debt (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Short term Debt history runs 5 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Short term Debt rose 19495.05% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 19495.05% YoY), while the FY2025 annual figure was $4.4 million, up 17446.49% from the prior year.
• Short term Debt was $4.4 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, roughly flat from $4.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.4 million in Q4 2025 to a low of $504.0 in Q2 2024.
• Historically, Short term Debt has averaged $838707.6 across 4 years, with a median of $22638.0 in 2025.
• The sharpest annual moves came in 2024 and 2026: Short term Debt slumped 99.89% in 2024, then jumped 19495.05% in 2026.
• A 4-year view of Short term Debt shows it stood at $3852.0 in 2023, then surged by 556.31% to $25281.0 in 2024, then surged by 17446.49% to $4.4 million in 2025, then changed by 0.0% to $4.4 million in 2026.
• The last three Short term Debt figures came in at $4.4 million (Q1 2026), $4.4 million (Q4 2025), and $8538.0 (Q3 2025), per Business Quant data.